ERIS Lifescience
Company Overview - January 14, 2025
ERIS Lifescience is a notable player in the Pharmaceuticals - Indian - Formulations industry, listed on both the BSE (Code: 540596) and NSE (Code: ERIS). As of the January 14, 2025, the company holds a market capitalization of INR 19654.37 crores, placing it among the top-performing companies in its sector.
With a current stock price of INR 1444.05, ERIS Lifescience has demonstrated a 51.73% return over the last year. Recent performance indicates fluctuations, with a 3.19% change in the past week and a 9.92% change over the last month. The company's all-time high stands at INR 1522.05, while its lowest-ever price was INR 321.00.
In terms of sales, ERIS Lifescience reported a revenue of INR 2498.12 crores, solidifying its position in the market. The average trading volume over the past month has been 122101 shares, with a more recent weekly average of 283024.
With the stock trading above its 50-day moving average of INR 1340.56, the company's technical indicators like MACD (30.95) signal positive trends.
Company Data
| Name | ERIS Lifescience |
|---|---|
| BSE Code | 540596 |
| NSE Code | ERIS |
| Industry | Pharmaceuticals - Indian - Formulations |
| Current Price | 1444.05 |
| Market Capitalization | 19654.37 |
| Sales | 2498.12 |
| Return over 3months | 2.15 |
| Return over 6months | 54.80 |
| Volume 1month average | 122101 |
| Volume 1week average | 283024 |
| Volume | 81288 |
| High price | 1522.05 |
| Low price | 809.15 |
| High price all time | 1522.05 |
| Low price all time | 321.00 |
| Return over 1day | 1.78 |
| Return over 1week | 3.19 |
| Return over 1month | 9.92 |
| Return over 1year | 51.73 |
| Return over 3years | 25.37 |
| Return over 5years | 25.20 |
| Volume 1year average | 232930 |
| DMA 50 | 1340.56 |
| DMA 200 | 1147.74 |
| DMA 50 previous day | 1337.39 |
| DMA 200 previous day | 1145.02 |
| MACD | 30.95 |
| MACD Signal | 17.66 |